SCJ:NYE-iShares MSCI Japan Small-Cap ETF (USD)

ETF | Japan Stock |

Last Closing

USD 78.98

Change

+0.05 (+0.06)%

Market Cap

N/A

Volume

8.30K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Japan Stock

Symbol Name Price(Change) Market Cap
FLJP Franklin FTSE Japan ETF

+0.01 (+0.03%)

USD 2.18B
DBJP Xtrackers MSCI Japan Hedged Eq..

+0.09 (+0.13%)

USD 0.44B
FLJH Franklin FTSE Japan Hedged ETF

-0.05 (-0.16%)

USD 0.08B
DFJ WisdomTree Japan SmallCap Divi..

+0.27 (+0.33%)

N/A
DXJ WisdomTree Japan Hedged Equity..

+0.25 (+0.24%)

N/A
EWJ iShares MSCI Japan ETF

+0.10 (+0.14%)

N/A
GSJY Goldman Sachs ActiveBeta® Jap..

-0.01 (-0.03%)

N/A
HEWJ iShares Currency Hedged MSCI J..

+0.01 (+0.02%)

N/A
JPXN iShares JPX-Nikkei 400 ETF

+0.16 (+0.21%)

N/A

ETFs Containing SCJ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Japan Stock) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.66% 30% F 56% F
Dividend Return 0.99% 50% F 17% F
Total Return 10.66% 20% F 50% F
Trailing 12 Months  
Capital Gain 19.94% 30% F 52% F
Dividend Return 2.50% 60% D- 34% F
Total Return 22.44% 30% F 49% F
Trailing 5 Years  
Capital Gain 10.59% 10% F 50% F
Dividend Return 5.06% 10% F 14% F
Total Return 15.65% 10% F 41% F
Average Annual (5 Year Horizon)  
Capital Gain 2.50% N/A N/A 47% F
Dividend Return 3.46% N/A N/A 41% F
Total Return 0.96% N/A N/A 22% F
Risk Return Profile  
Volatility (Standard Deviation) 16.42% N/A N/A 61% D-
Risk Adjusted Return 21.05% N/A N/A 39% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike